Cargando…

Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing

Detalles Bibliográficos
Autores principales:	Rodrigues, Pedro M., Banales, Jesus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768554/ https://www.ncbi.nlm.nih.gov/pubmed/33031804 http://dx.doi.org/10.1016/j.jcmgh.2020.09.005

Ejemplares similares

Highlight report: Toxicogenomics atlas of rat hepatotoxicants
por: Seidel, Florian
Publicado: (2018)

Liver library: creating a microarray for hepatotoxicants.
por: McGovern, V
Publicado: (2003)

NRF2 Protection against Liver Injury Produced by Various Hepatotoxicants
por: Liu, Jie, et al.
Publicado: (2013)

High-content analysis of in vitro hepatocyte injury induced by various hepatotoxicants
por: Tham, Nga T. T., et al.
Publicado: (2019)

Gene Expression Analysis of the Hepatotoxicant Methapyrilene in Primary Rat Hepatocytes: An Interlaboratory Study
por: Beekman, Johanna M., et al.
Publicado: (2006)

Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes
por: Szalowska, Ewa, et al.
Publicado: (2013)

Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.
por: Ulrich, Roger G, et al.
Publicado: (2004)

Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants
por: Huang, Lingkang, et al.
Publicado: (2008)

NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
por: Tarantino, Giovanni
Publicado: (2013)

NASH: Connecting the dots with patients in mind
por: Cryer, Donna R.
Publicado: (2020)

Something to mTORC About in NASH
por: Finck, Brian N.
Publicado: (2022)

Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States
por: Eeckhoute, Jérôme
Publicado: (2022)

Letter from Dr. Nash
por: Hart, James A.
Publicado: (1875)

Targeting bile acids and lipotoxicity for NASH treatment
por: Chiang, John Y. L.
Publicado: (2017)

Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases
por: Cuevas-Diaz Duran, Raquel, et al.
Publicado: (2022)

NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease
por: Manka, Paul, et al.
Publicado: (2020)

Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
por: Agirre-Lizaso, Aloña, et al.
Publicado: (2023)

PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
por: Olaizola, Paula, et al.
Publicado: (2023)

MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020)

Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021)

NASH and Systemic Complications: From Basic to Clinical Research
por: Baumgartner, Sabine, et al.
Publicado: (2021)

Multicytokine-producing CD4(+) T cells characterize the livers of patients with NASH
por: Woestemeier, Anna, et al.
Publicado: (2023)

Beyond Fibroblast Heterogeneity: What Single-Cell RNA Sequencing Tells Us
por: Zhou, Yong
Publicado: (2019)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment
por: Nance, Rebecca L., et al.
Publicado: (2023)

Single cell and immunity: Better understanding immune cell heterogeneities with single cell sequencing
por: Chen, Dongsheng, et al.
Publicado: (2022)

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
por: Wang, Zhong-Yi, et al.
Publicado: (2021)

Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
por: Sun, Yunfan, et al.
Publicado: (2021)

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer
por: Papadaki, Maria A., et al.
Publicado: (2022)

NRF2 Induction for NASH Treatment: A New Hope Rises
por: Rojo de la Vega, Montserrat, et al.
Publicado: (2018)

Osr1 Is a Critical Regulator of Macrophage Polarization in NASH Progression
por: Lee, Jin, et al.
Publicado: (2023)

MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH
por: Zarfeshani, Aida, et al.
Publicado: (2015)

BET Inhibition Improves NASH and Liver Fibrosis
por: Middleton, Sarah A., et al.
Publicado: (2018)

Alarming increase of NASH as cause of liver cancer
por: Craciun, Ana, et al.
Publicado: (2022)

Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
por: Kaur, Savneet, et al.
Publicado: (2019)

HIF2α Activation in NASH: A New Force Pushing Toward HCC
por: Clavería-Cabello, Alex, et al.
Publicado: (2021)

Protection of muscle nuclei
por: Volk, Talila, et al.
Publicado: (2015)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dskslu9151h1hrnfbpfh906qgs